Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-First...ans,especiallythe27millionlivingwithuntreated hear...logistCindyBeyer. ,, Dr.Beyer,seniorvicepreside...ngcareand hearingaids companies,saidstudieshavelin...ion,"whichcaneasilybeintensifiedatholidaygathering...
(Date:11/25/2009)...,, HARBIN,China,Nov.25/PRNewswire-Asia-FirstC..."or"theCompany")(Nasdaq: CSKI ),a,leadingfullyinte...over-the-counterdrugsinthePeople,sRepublicofChina(...theChineseNationalInstitutefor,theControlofPharmac...ortwoofitsnewproducts:itsDiagnosticKitforHumanPros...
(Date:11/25/2009)...,, EASTBRUNSWICK,N.J.,Nov.25/PRNewswire/--Swi...tdigitalRadiography( ddR )systems,announcedtodayth...storwithalongtermviewtowardsgrowingSwissray,smedic...ntellectualproperty,aswellascontractsandinventory....omovetothenextleveloftechnologicaladvancementswith...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 1Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 2Local Medicare Advantage Plan Gets Five Star Ratings from Medicare 60771 3The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 1ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 60765 2
...efer Orapred ODT Over Liquid, ALPHARETTA, Ga., Mar...s announced today survey results showing that,chil...hosphate,orally disintegrating tablets) over liqui...ck survey involving more than,900 children (n=973)...d Orapred ODT over liquid versions. The results al...
...7 /PRNewswire-FirstCall/ -- Baxter,International I...adjuvant-free investigational pandemic H5N1 influe...ical trial of the candidate,vaccine in Europe to c...ndicated that Baxter,s H5N1 candidate,vaccine is h...ntial,levels of cross immunity against widely dive...
Other Medicine Technology:Orapred ODT Tastes Good 2Orapred ODT Tastes Good 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5
(Date:11/27/2009)...S,Nov.27/PRNewswire-USNewswire/--Consideredahighly...o,solidorgantransplantationisnowalife-savingmainst...ogatheredattheWinspearOperaHouseinDallasonNov.11.L...tocelebratethe25thanniversaryofBaylorRegionalTrans...ransplantintheUnitedStates. ,, Itwas25yearsagot...
(Date:11/27/2009)...LY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGarmin...mdedicatedtoethicalsportinganddevelopingthenextgen...becomeTeamGarmin-TransitionswiththeadditionofTrans...icalistheworld,sleadingmanufacturerofadaptiveeyewe...thewidestselectionofspectaclelensessuchasTransitio...
(Date:11/27/2009)...ycling plus low-emission vehicles may reduce futur...IDAY, Nov. 27 (HealthDay News) -- Encouraging city...s would offer much greater public health benefits ... researchers have found. , The study compared t... urban land transport scenarios for London, Englan...
(Date:11/27/2009)... Voyant Health™ announced today ...licensed its TraumaCad Enterprise orthopedic templ...olution. , (PRWEB) Novemb...y that Spectrum Health (Grand Rapids, Michigan) ha...plating solution and its TraumaCad Extend workflow...
(Date:11/27/2009)... Three new interactive anatomy educati...; Wilkins expand health sciences learning opportun... Durham, NC (Vocus) November 27, 2009 -- ...ins (LWW), a division of Wolters Kluwer Health, to...y education apps on the App Store. Clemente’...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...e light on mysterious condition , , WEDNES... that may increase the risk of autism, particularl.... , Analysis of the DNA of 1,046 members of famili...utism, the researchers reported. , This variant of...
...re in people with Down syndrome, whose overall can...eneral population. Since they have an extra copy o...th Down syndrome may be getting an extra dose of o...n, popularized the notion that they might be benef...
...hlighted in June 2009 issue of Pregnancy , , BAL...ookin.com its "Website We Can,t Live Without" for ... provides information on bed rest and preterm la...lace to talk about it, on the online forum," says ...
...California $70 Million In Health Care Costs And Pr...lose September 2009 , , SAN FRANCISCO, May 20 Fu...ely eliminated from the California state budget. B...cal professionals. , , The California Poison Con...
... Orasi Medical, Inc. announced today that it has ... , , The company will use this capital to expand ...o the pharmaceutical and clinical markets. Pharmac...cussions with several pharmaceutical companies to ...
...p Designed to Urge Families to Take Action against... AstraZeneca (NYSE: AZN ) today kicks off the 20...Artery Explorer -- a state-of-the-art, multisensor... a row, AstraZeneca has partnered with the Nationa...
Other Medicine News:Health News:Gene Gives Clues to Why Autism More Common in Boys 2Health News:Why do people with Down syndrome have less cancer? 2Health News:Why do people with Down syndrome have less cancer? 3Health News:Pregnancy Magazine Names KeepEmCookin.com its 'Website We Can't Live Without' 2Health News:Governor Eliminates California's Poison Control Service 2Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 2Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 3Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 4Health News:AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities 5
Digital Microscope Camera - DMC2
Bench Top Vertical Airflow Cabinets Production Protection
Console Horizontal Airflow Cabinet
Heated Processing Chamber
Medicine Products: